The COVID-19 pandemic had a tremendous impact on the Orthobiologics Market. The virus forced the postponement and cancellation of elective surgeries, including orthobiologic procedures, as the healthcare system was overburdened and resources were diverted to tackle it. As a result, demand for orthobiologics was significantly reduced in the early stages of the epidemic. The market did, however, gradually recover as healthcare facilities adjusted to the new normal, led by the resumption of elective procedures and the rising popularity of regenerative therapies.

The Orthobiologics Market is anticipated to pick up steam and show consistent growth in the years to come as the world begins to recover from the pandemic. Aside from that, the pandemic hastened the use of telemedicine and digital health solutions, allowing medical professionals to remotely evaluate and recommend orthobiologics therapies. The pandemic's urgency also prompted continuous research and development efforts in the field of regenerative medicine, opening the door for fresh and ground-breaking orthobiologic solutions.